What Factors Are Associated With Prognosis of Rotator Cuff Disorder After Subacromial Hyaluronic Acid Injection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-08

Study Completion Date

2019-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the correlations between structure of supraspinatus tendon (impingement, tendinopathy or partial tear, as well as full thickness tear) on ultrasonography and its response to subacromial hyaluronic acid injection in rotator cuff disease patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Rotator Interval Injection Versus Intraarticular Hydrodilatation in Frozen Shoulder

NCT03678038

Adhesive Capsulitis

COMPLETED NA

Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in Rotator Cuff Disease

NCT01735058

Subacromial Impingement Syndrome

UNKNOWN PHASE2/PHASE3

Comparison of Strength and Constant Score Pre- and Post-Subacromial Injection for Full Thickness Rotator Cuff Tears

NCT02693444

Rotator Cuff Subacromial Impingement Syndrome

WITHDRAWN NA

Standardized and Modified Corticosteroid Subacromial Injection for Shoulder Impingement Syndrome

NCT03148353

Shoulder Impingement

COMPLETED NA

Dual-target Ultrasound Guided Corticosteroid Injection for Shoulder Impingement Syndrome

NCT04219527

Shoulder Impingement

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective: To evaluate the correlations between structure of supraspinatus tendon (impingement, tendinopathy or partial tear, as well as full thickness tear) on ultrasonography and its response to subacromial hyaluronic acid injection in rotator cuff disease patients and also investigate the factors associated with clinically important improvement after subdeltoid hyaluronic acid for rotator cuff disorder.

Design: Prospective, longitudinal comparison study.

Participants: Patients with rotator cuff disease

Intervention: Three subacromial injection with hyaluronic acid with 2 week-interval.

Main Outcome Measures: Visual analog scale (VAS) of the shoulder pain, Constant score, SPADI score, and angles of active shoulder range of motion (flexion, abduction, external rotation, and internal rotation) at pre-treatment, post-treatment at week 4 and post-treatment at week 12.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rotator Cuff Impingement Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

patients with rotator cuff disorders receving subacromial hyaluronic acid injection

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

outcome assessor does not know the rotator cuff condition of patients

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with rotator cuff disorders

patients with rotator cuff disorders, including impingment, rotator cuff disorders and rotator cuff tear receiving hyaluronic acid injection over subacromial bursa

Group Type EXPERIMENTAL

Hyaluronic Acid

Intervention Type DRUG

Hyaluronic Acid 2cc into subacromial bursa at weeks 0, 2 and 4

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hyaluronic Acid

Hyaluronic Acid 2cc into subacromial bursa at weeks 0, 2 and 4

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

hyruan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. with clinically and ultrasonographically diagnosed rotator cuff disease of the shoulder-impingement, tendinosis and tear;
2. who reported shoulder pain more than 3 months;

Exclusion Criteria

1. presence of another medical or psychological condition, including cancer, rheumatoid arthritis, endocrine disease (i.e., diabetes), major depression, or schizophrenia;
2. previous major trauma history at currently affected shoulder; 3 primary osteoarthritis of the glenohumeral joint in a simple radiograph; 4previous injection history at the affected shoulder within 3 months

Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No